Whilst recent studies of HCWs report on the longitudinal evaluation of SARS-CoV-2 antibodies (32–35), we utilise a hospital setting to screen the performance of the PanbioTM COVID-19 IgG/IgM rapid test. Here, CD40LG is linked to COVID-19.